Getty Images
Check Up: A bit of progress for the health sector
Health & Biotech
share
Here’s our fortnightly wrap of all the news driving ASX health stocks.
The health sector made a bit of progress over the last fortnight, with 64 small-cap life sciences gaining ground and just 52 losing it. Another 15 companies were flat.
| Code | Name | Price (I) | 2 Week % Return | 1 Year % Return | Market Cap |
|---|---|---|---|---|---|
| RHY | RHYTHM BIOSCIENCES | 0.22 | 95 | 30 | $ 41,306,640.00 |
| OIL | OPTISCAN IMAGING | 0.12 | 85 | 200 | $ 57,333,456.00 |
| RNO | RHINOMED | 0.125 | 81 | -37 | $ 36,802,324.00 |
| AGH | ALTHEA GROUP HOLDINGS | 0.59 | 58 | -22 | $ 139,986,000.00 |
| JHL | JAYEX HEALTHCARE | 0.045 | 50 | 50 | $ 9,061,336.00 |
| VTI | VISIONEERING TECH-CDI | 0.032 | 45 | -51 | $ 31,018,124.00 |
| PAB | PATRYS | 0.016 | 42 | -26 | $ 24,312,060.00 |
| BPH | BPH ENERGY | 0.043 | 39 | 165 | $ 25,226,938.00 |
| APH | AUSTRALIAN PRIMARY HEMP | 0.185 | 35 | -20 | $ 12,207,149.00 |
| FFC | FARMAFORCE | 0.07 | 35 | -50 | $ 9,013,969.00 |
| RSH | RESPIRI | 0.225 | 34 | 139 | $ 140,360,560.00 |
| BOT | BOTANIX PHARMACEUTICALS | 0.061 | 34 | -75 | $ 61,279,976.00 |
| AHX | APIAM ANIMAL HEALTH | 0.63 | 25 | 22 | $ 74,039,184.00 |
| MDC | MEDLAB CLINICAL | 0.175 | 23 | -63 | $ 51,740,000.00 |
| SOM | SOMNOMED | 2.12 | 23 | 8 | $ 161,794,464.00 |
| THC | THC GLOBAL GROUP | 0.25 | 22 | -38 | $ 48,393,888.00 |
| OSL | ONCOSIL MEDICAL | 0.14 | 22 | 93 | $ 116,004,128.00 |
| ANR | ANATARA LIFESCIENCES | 0.23 | 21 | 5 | $ 11,483,564.00 |
| ATX | AMPLIA THERAPEUTICS | 0.16 | 19 | 109 | $ 18,676,216.00 |
| PYC | PYC THERAPEUTICS | 0.145 | 17 | 187 | $ 395,763,040.00 |
| LBT | LBT INNOVATIONS | 0.14 | 17 | 8 | $ 40,364,780.00 |
| NC6 | NANOLLOSE | 0.078 | 16 | 8 | $ 8,248,499.50 |
| CYC | CYCLOPHARM | 1.8 | 15 | 25 | $ 127,235,008.00 |
| SVA | SIMAVITA -CDI | 0.023 | 15 | 156 | $ 26,538,916.00 |
| TLX | TELIX PHARMACEUTICALS | 1.88 | 14 | 37 | $ 482,494,432.00 |
| LSH | LIFESPOT HEALTH | 0.04 | 14 | -33 | $ 3,906,939.75 |
| AC8 | AUSCANN GROUP HOLDINGS | 0.17 | 14 | -55 | $ 52,312,812.00 |
| IMM | IMMUTEP | 0.215 | 13 | -2 | $ 104,840,648.00 |
| CTE | CRYOSITE | 0.19 | 12 | 342 | $ 8,903,317.00 |
| ANP | ANTISENSE THERAPEUTICS | 0.1 | 12 | 104 | $ 46,942,864.00 |
| ADO | ANTEOTECH | 0.061 | 11 | 371 | $ 100,523,400.00 |
| VLS | VITA LIFE SCIENCES | 0.97 | 10 | 58 | $ 52,460,132.00 |
| CAN | CANN GROUP | 0.43 | 10 | -75 | $ 114,289,768.00 |
| RCE | RECCE PHARMACEUTICALS | 1.6875 | 9 | 600 | $ 245,374,368.00 |
| IDT | IDT AUSTRALIA | 0.185 | 9 | 28 | $ 44,272,912.00 |
| OPT | OPTHEA | 2.94 | 8 | -16 | $ 759,024,896.00 |
| ALC | ALCIDION GROUP | 0.145 | 8 | -32 | $ 138,697,168.00 |
| MMJ | MMJ GROUP HOLDINGS | 0.098 | 8 | -59 | $ 22,535,490.00 |
| 4DX | 4DMEDICAL | 1.58 | 7 | $ 407,734,112.00 | |
| UBI | UNIVERSAL BIOSENSORS INC-CDI | 0.34 | 6 | 79 | $ 60,374,432.00 |
| IPD | IMPEDIMED | 0.07 | 6 | -55 | $ 73,479,976.00 |
| CPH | CRESO PHARMA | 0.037 | 6 | -91 | $ 13,656,396.00 |
| CGS | COGSTATE | 0.72 | 6 | 161 | $ 123,193,208.00 |
| RGS | REGENEUS | 0.19 | 6 | 138 | $ 57,054,032.00 |
| 1AD | ADALTA | 0.105 | 5 | -18 | $ 25,743,464.00 |
| OCC | ORTHOCELL | 0.42 | 5 | 9 | $ 79,458,392.00 |
| EYE | NOVA EYE MEDICAL | 0.325 | 5 | 20 | $ 46,670,368.00 |
| PTX | PRESCIENT THERAPEUTICS | 0.071 | 4 | 29 | $ 46,119,816.00 |
| CDX | CARDIEX | 0.057 | 4 | 100 | $ 46,911,280.00 |
| PCK | PAINCHEK | 0.092 | 3 | -69 | $ 103,666,040.00 |
| PNV | POLYNOVO | 2.29 | 3 | 9 | $ 1,487,448,064.00 |
| NOX | NOXOPHARM | 0.345 | 3 | -7 | $ 69,303,192.00 |
| ONT | 1300 SMILES | 6.3 | 3 | 12 | $ 149,173,824.00 |
| CYP | CYNATA THERAPEUTICS | 0.925 | 3 | -35 | $ 107,754,080.00 |
| ACR | ACRUX | 0.185 | 3 | 0 | $ 31,218,270.00 |
| BIT | BIOTRON | 0.098 | 2 | 44 | $ 68,789,408.00 |
| CAJ | CAPITOL HEALTH | 0.255 | 2 | 20 | $ 261,145,440.00 |
| HLA | HEALTHIA | 1 | 2 | 13 | $ 63,034,652.00 |
| HCT | HOLISTA COLLTECH | 0.06 | 2 | -12 | $ 16,520,945.00 |
| ZLD | ZELIRA THERAPEUTICS | 0.06 | 2 | -15 | $ 68,537,160.00 |
| AZV | AZURE HEALTHCARE | 0.081 | 1 | 4 | $ 23,019,306.00 |
| PBP | PROBIOTEC | 1.825 | 1 | 14 | $ 136,471,440.00 |
| ARX | AROA BIOSURGERY | 1.3 | 1 | $ 390,097,440.00 | |
| SDI | SDI | 0.71 | 1 | -4 | $ 84,394,528.00 |
| AMT | ALLEGRA ORTHOPAEDICS | 0.19 | 0 | 73 | $ 19,834,582.00 |
| IHL | INCANNEX HEALTHCARE | 0.06 | 0 | -26 | $ 47,388,620.00 |
| ACW | ACTINOGEN MEDICAL | 0.031 | 0 | 250 | $ 31,254,476.00 |
| RAP | RESAPP HEALTH | 0.115 | 0 | -38 | $ 90,614,336.00 |
| SCU | STEMCELL UNITED | 0.012 | 0 | -25 | $ 7,699,300.50 |
| UCM | USCOM | 0.17 | 0 | 48 | $ 25,587,256.00 |
| ALT | ANALYTICA | 0.002 | 0 | -33 | $ 7,039,224.50 |
| TD1 | TALI DIGITAL | 0.026 | 0 | 136 | $ 19,481,936.00 |
| BD1 | BARD1 LIFE SCIENCES | 0.028 | 0 | -28 | $ 67,046,852.00 |
| IVX | INVION | 0.011 | 0 | -27 | $ 60,539,588.00 |
| RAC | RACE ONCOLOGY | 0.8 | 0 | 591 | $ 101,399,368.00 |
| MX1 | MICRO-X | 0.185 | 0 | -34 | $ 66,076,052.00 |
| BNO | BIONOMICS | 0.155 | 0 | 275 | $ 93,991,512.00 |
| CP1 | CANNPAL ANIMAL THERAPEUTICS | 0.12 | 0 | -23 | $ 11,175,000.00 |
| NSB | NEUROSCIENTIFIC BIOPHARMACEU | 0.24 | 0 | 0 | $ 18,815,756.00 |
| NXS | NEXT SCIENCE | 1.32 | -1 | -54 | $ 239,641,616.00 |
| PAL | PALLA PHARMA | 0.77 | -1 | -19 | $ 96,979,944.00 |
| CMP | COMPUMEDICS | 0.38 | -1 | -40 | $ 67,321,920.00 |
| MVP | MEDICAL DEVELOPMENTS INTERNA | 5.76 | -1 | 22 | $ 374,053,888.00 |
| ICR | INTELICARE HOLDINGS | 0.335 | -1 | $ 24,421,402.00 | |
| IMC | IMMURON | 0.295 | -2 | 177 | $ 68,350,504.00 |
| OVN | OVENTUS MEDICAL | 0.255 | -2 | -54 | $ 40,356,916.00 |
| NYR | NYRADA INC-CDI | 0.205 | -2 | $ 22,423,664.00 | |
| EXL | ELIXINOL GLOBAL | 0.16 | -3 | -92 | $ 30,853,930.00 |
| RHT | RESONANCE HEALTH | 0.135 | -4 | 8 | $ 59,909,480.00 |
| BWX | BWX | 4.76 | -4 | 40 | $ 661,438,528.00 |
| PSQ | PACIFIC SMILES GROUP | 1.78 | -4 | 18 | $ 273,257,664.00 |
| MXC | MGC PHARMACEUTICALS | 0.024 | -4 | -40 | $ 39,379,004.00 |
| ONE | ONEVIEW HEALTHCARE PLC-CDI | 0.045 | -4 | -83 | $ 7,796,316.50 |
| ICS | ICSGLOBAL | 1.85 | -4 | 71 | $ 19,617,436.00 |
| NEU | NEUREN PHARMACEUTICALS | 1.195 | -5 | -40 | $ 140,541,696.00 |
| M7T | MACH7 TECHNOLOGIES | 1 | -5 | 54 | $ 234,376,704.00 |
| ZNO | ZOONO GROUP | 1.965 | -6 | 2671 | $ 321,498,976.00 |
| LCT | LIVING CELL TECHNOLOGIES | 0.016 | -6 | -11 | $ 9,143,056.00 |
| SUD | SUDA PHARMACEUTICALS | 0.044 | -6 | -48 | $ 13,457,266.00 |
| VHT | VOLPARA HEALTH TECHNOLOGIES | 1.31 | -7 | -17 | $ 326,064,800.00 |
| S66 | STAR COMBO PHARMA | 0.34 | -7 | -27 | $ 45,431,560.00 |
| PAR | PARADIGM BIOPHARMACEUTICALS | 2.53 | -7 | 20 | $ 578,753,536.00 |
| GLH | GLOBAL HEALTH | 0.225 | -8 | 92 | $ 9,472,122.00 |
| PGC | PARAGON CARE | 0.165 | -8 | -58 | $ 55,751,072.00 |
| MEB | MEDIBIO | 0.0115 | -8 | -19 | $ 14,824,288.00 |
| DVL | DORSAVI | 0.021 | -9 | -65 | $ 4,859,978.00 |
| MEM | MEMPHASYS | 0.105 | -9 | 123 | $ 79,219,760.00 |
| 1ST | 1ST GROUP | 0.031 | -9 | -53 | $ 13,163,124.00 |
| GSS | GENETIC SIGNATURES | 1.99 | -9 | 96 | $ 288,185,312.00 |
| IMU | IMUGENE | 0.049 | -9 | 104 | $ 220,025,152.00 |
| MDR | MEDADVISOR | 0.42 | -10 | 28 | $ 103,621,568.00 |
| CDY | CELLMID | 0.099 | -10 | -59 | $ 12,399,440.00 |
| KZA | KAZIA THERAPEUTICS | 0.99 | -10 | 128 | $ 93,677,136.00 |
| IBX | IMAGION BIOSYSTEMS | 0.085 | -10 | 127 | $ 78,875,864.00 |
| MVF | MONASH IVF GROUP | 0.565 | -10 | -40 | $ 220,143,680.00 |
| OSP | OSPREY MEDICAL INC-CDI | 0.024 | -11 | -43 | $ 37,469,720.00 |
| AVE | AVECHO BIOTECHNOLOGY | 0.008 | -11 | 33 | $ 12,779,659.00 |
| AT1 | ATOMO DIAGNOSTICS | 0.36 | -11 | $ 202,445,216.00 | |
| OSX | OSTEOPORE | 0.575 | -11 | $ 60,979,484.00 | |
| ADR | ADHERIUM | 0.03 | -12 | 15 | $ 19,944,358.00 |
| ATH | ALTERITY THERAPEUTICS | 0.047 | -13 | 64 | $ 49,910,184.00 |
| JHC | JAPARA HEALTHCARE | 0.395 | -13 | -65 | $ 102,890,224.00 |
| PIQ | PROTEOMICS INTERNATIONAL LAB | 0.48 | -14 | 32 | $ 44,354,820.00 |
| BXN | BIOXYNE | 0.012 | -14 | -43 | $ 7,681,745.00 |
| GTG | GENETIC TECHNOLOGIES | 0.009 | -15 | 66 | $ 70,224,680.00 |
| GMV | G MEDICAL INNOVATION HOLDING | 0.032 | -17 | -58 | $ 28,520,274.00 |
| PXS | PHARMAXIS | 0.078 | -18 | -57 | $ 31,268,674.00 |
| NTI | NEUROTECH INTERNATIONAL | 0.012 | -20 | -14 | $ 4,662,777.00 |
| VBS | VECTUS BIOSYSTEMS | 0.89 | -21 | 62 | $ 21,052,786.00 |
| PAA | PHARMAUST | 0.13 | -34 | -11 | $ 39,480,756.00 |
| DXB | DIMERIX | 0.265 | -62 | 190 | $ 53,392,312.00 |
The biggest gainer was Rhythm Bioscience (ASX:RHY), whose shares closed Wednesday at 18.5c, up from around 8c in early August, after the company last week recruited its first patient into a clinical trial of its low-cost blood test for the early detection of colorectal cancer.
As previously reported, Rhythm says Colostat test will make life easier for doctors, because they won’t need to send patients for unnecessary colonoscopies. It would replace the complicated stool tests.
Rhinomed (ASX:RNO) soared 81 per cent after the airway technology company said it had created a less invasive nasal swab that could be self-administered to test for flu and “coronavirus strains”.
Althea Group (ASX:AGH) was the top-performing pot stock, up 58 per cent, climbing after its Canadian subsidiary obtained its Standard Processing Licence.
Optiscan Imaging (ASX:OIL) was the second biggest gainer for the period, but in a response to an ASX query, had no real explanation for the recent rise in its securities.
On the flip side, Dimerix (ASX:DXB) shares lost 62 per cent of their value after the clinical trial of its CCR2 blocker DMX-200 failed to meet clinical endpoints in a test of how well it helped 40 patients with diabetic kidney disease. The biotech says the drug candidate did assist the 26 worst effected patients, however, and plans to further analyse the study results.
PharmAust (ASX:PAA) declined by about a third after its US partner declined an option agreement to further develop its drug candidate for animal cancer.
